Identification of an adipogenesis gene, CEBPA, in an adipocyte subtype and network linked to insulin resistance and obesity
Year: 2026
Type: article
Abstract: Human adipocytes are heterogeneous; however, cellular regulators linking obesity-related cardiometabolic diseases to adipocyte heterogeneity remain unknown. Leveraging subcutaneous adipose tissue (SAT) single-nucleus RNA-sequencing (snRNA-seq) data from three cohorts ( n = 331), we identify an adipocyte subtype, Ad2, with 202 marker genes. The proportions of Ad2 associate with cardiometabolic traits (CMTs) and its marker genes significantly overlap with genes in an adipocyte-specific, highly preserved co-expression network, AdNetwork2, that comprises 212 CMT-associated genes. A cis -expression quantitative trait locus variant, rs8111294, of CEBPA , an adipogenesis transcription factor (TF) in AdNetwork2, has allele-specific downstream effects on other AdNetwork2 TFs in trans . We replicated these cis -linked trans effects in an independent dataset. For CEBPA target TFs, CEBPB and KLF15 , we functionally validate the presence of their target genes in AdNetwork2. Overall, we uncover cascading, multilayered effects of CEBPA , CEBPB, and KLF15 on 170 CMT genes in AdNetwork2, elucidating cell-type level mechanisms contributing to context-specific adipocyte heterogeneity.
Source: iScience
Authors: Zitian Wang, Seung Hyuk T. Lee, Asha Kar, Marcus Alvarez, Heather M. Stringham, Kyla Z. Gelev, Mihir G. Sukhatme, Sini Heinonen, Tuure Saarinen, Maija Vaittinen, Dorota Kaminska, Hilkka Peltoniemi, Anne Juuti, Ville Männistö, Jussi Pihlajamäki, Minna U. Kaikkonen, Kirsi H. Pietiläinen, Markku Laakso, Laura J. Scott, Karen L. Mohlke, Päivi Pajukanta
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,240
Funders: Helsingin Yliopisto, Suomen Lääketieteen Säätiö, European Commission, Academy of Finland, Kuopion Yliopistollinen Sairaala, Novo Nordisk, Sydäntutkimussäätiö, Sigrid Juséliuksen Säätiö, Paavo Nurmen Säätiö, Novo Nordisk Fonden, Diabetestutkimussäätiö, National Institutes of Health, University of California, Los Angeles, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, HORIZON EUROPE European Innovation Council
Awards: G1224646995, G1229847758, Novel targets to activate adipose tissue metabolism for the treatment of obesity, G1325181340, G1509028116, G1517598383, G1714132465, ADIPOSE AND MUSCLE TISSUE MITOCHONDRIAL PROFILING AS A KEY TO RENEWING THE TREATMENT OF OBESITY, G1820233071, G1875502402, G2049747399, G2384427189, G2583954406, G2811085312, G2996280776, G3494606022, G3850253215, G3866446495, G3871240750, G3947144878, G4043554698, G4065964368, G4180513299, G4287685855, G4415933063, G4618823813, G4741968299, G4892916650, G4976537738, G5054526510, G5115434385, G5242406232, G551036691, G5933764796, Individualized treatments for obesity based on mitochondrial biology, G623802957, G6266754447, MultiomIcs based Risk stratification of Atherosclerotic CardiovascuLar disEase, FLY HIGHER - Shaping the new evolving generation of aeronautic professionals, G6635489528, G7134263544, G7325495115, Adipose tissue dysfunction as a driver of steatotic liver disease: Novel mechanisms and emerging therapeutic strategies, G7773052359, G7852328768, G7882649875, G8363947306, G8374335932, G8419078628, G8749904515, G8793474095, G8880324339, G8966511090, Genetic epidemiology of rare and regulatory variants for metabolic traits, Genetics of adipose cell-type expression and cardiometabolic traits, Identifying Genes for Type 2 Diabetes: FUSION, G962776880, G96990336
OpenAlex ID: W7237196826
